Centre Setup and Expansion Northwell Health opens USD 4.3 Mn practice in Astoria The location offers access to specialists at Lenox Hill Hospital and Long Island Jewish Forest Hills. The facility includes 16 exam rooms and is staffed by 10 physicians. Read More>>Executive Movements Labcorp appoints Dr. Paul Rothman to the Board of Directors The company is expanding the Board to 12 directors. Dr. Rothman is a graduate of MIT and Yale University. He brings expertise to Labcorp as a leading global life sciences company providing essential information for informed healthcare decisions. Read More>> Tenet Healthcare names Darrin Cook as a chief operating officer for its Mass. Market Darren Cook will be the CEO of Saint Vincent Hospital in Worcester and the Massachusetts market. He has over 20 years of healthcare administration experience, including his recent role at Palm Beach Gardens Medical Center. Previously, he served in the Army as a medical specialist. Read More>> KPJ Healthcare appoints Mohamad Farid Salim as COO KPJ Healthcare appoints Datuk Mohamad Farid Salim as COO. With a remarkable 30 years of experience within the group, Farid has displayed exceptional leadership in various roles. His appointment aims to strengthen operational aspects, supply chain management, and customer service in KPJ Healthcare’s pursuit of redefining the healthcare industry. Read More>>Mass Hiring Northeast Ambulance Service hosts open recruitment day in Gateshead The Northeast Ambulance Service is seeking new staff for various roles. The available positions include health advisors, call handlers, nurses, paramedics, and clinical care assistants. The event is at the NEAS education center in Dukesway in Team. Read More>>Product Launch Sword Health launches the world’s first platform to predict, prevent and treat pain Sword Health launches a platform to predict, prevent, and treat pain to address the diverse experiences of 60% of adults who experience significant physical pain annually. The platform integrates solutions into a single platform, building on Sword’s leadership in back, joint, and muscle pain care. Read More>> Solutionreach announces cutting-edge Generative AI capabilities for review management Solutionreach introduces generative AI tools to streamline online review management in its patient engagement platform. The platform boosts healthcare practices’ revenue and patient satisfaction with instant personalized responses, brand sentiment monitoring, and precise feedback analysis. Read More>> Tempus launches an AI assistant for thousands of oncologists Tempus introduces Tempus One, a voice-and-text assistant that provides physicians with easier access to patient data. The AI assistant has launched ahead of the American Society of Clinical Oncology meeting and will initially be available to the 6,000 doctors prescribing Tempus’ diagnostic tests. Read More>>Financial and Market Activity Dana-Farber Cancer Institute posts USD 54.3 Mn operating income in 1st half of 2023 Despite a 16.4% increase in operating expenses to USD 1.4 Bn, the institute reported a total operating revenue of approx. USD 1.5 Bn, resulting in an overall income of USD 110.3 Mn. Read More>>
Key Insights and Signals in Medical Devices
Merger and Acquisition Lonza acquires Synaffix in ADC Deal Lonza has acquired Synaffix, a biotechnology company from the Netherlands known for its antibody-drug conjugate technology platform. The deal involves an initial cash payment of USD 107 million and additional performance-based consideration of up to USD 64 million. Synaffix will continue to operate under its name. Read More>>Centre Setup and Expansion OMRON Healthcare to set up a factory in Mahindra Lifespaces’ industrial park in Chennai OMRON Healthcare plans to establish a factory for manufacturing blood pressure monitors at Mahindra Lifespace Developers’ industrial park in Chennai. The factory will be built over 6.02 acres and is expected to begin operations in March 2025, and will cater primarily to the domestic market. Read More>>Executive Movements Nevro names new Chief Commercial Officer Nevro Corp. has appointed Greg Siller as Senior Vice President and Chief Commercial Officer, effective June 19, 2023. Mr. Siller replaces Niamh Pellegrini. Siller brings extensive experience in commercial strategies and successful leadership in the medical device industry, particularly in the field of interventional spine. Read More>> Dentsply Sirona appoints Emily P. Miner as Senior Vice President, Quality and Regulatory Miner brings over 15 years of experience in the medical device and pharmaceutical industries, with expertise in quality and regulatory management. She joins Dentsply Sirona from her previous role as Senior Vice President, Global Quality and Regulatory at Terumo Cardiovascular. Read More>>Product Launch Penumbra (PEN) launches new technology for Blood Clot Removal PEN has introduced Lightning Bolt 7, a technology that rapidly removes blood clots using modulated aspiration. This advanced system combines imaging, AI, and minimally invasive devices to treat stroke and vascular conditions. With its new aspiration technology and microprocessor algorithm, Lightning Bolt 7 offers faster and safer clot removal, promoting an endovascular-first approach. Read More>> Agilent announces the launch of a software package for analyzing real-time cell analysis data Agilent Technologies has launched the enhanced xCELLigence RTCA Software Pro Version 2.8, offering improved capabilities for real-time cell analysis. The software ensures data integrity and compliance with regulatory requirements in pharmaceutical manufacturing. Read More>>Financial and Market Activity PolyNovo achieves record monthly sales of USD 7.2Mn in May PolyNovo achieves record monthly sales of USD 7.2 million in May, demonstrating strong growth and expansion in global markets. The company’s total revenue for the 11 months to May 31 reached USD 59.1 million, a 54.5% increase compared to the previous year. Read More>>
Key Insights and Signals in Pharmaceutical
Product Launch Lupin launches HIV drug Darunavir in the US Lupin has launched Darunavir Tablets in 600 mg and 800 mg strengths as a generic equivalent of Janssen’s Prezista Tablets. Darunavir is used for the treatment of HIV-1 infections and helps control the virus when taken in combination with other HIV drugs. Read More>> Teva Pharmaceuticals unveils RealWorld Data and Patient Titration Kit for AUSTEDO Teva Pharmaceuticals presented real-world data for AUSTEDO tablets, used for treating tardive dyskinesia and chorea associated with Huntington’s disease. They also introduced a 4-week patient titration kit to help with dosage adjustment and minimize side effects. AUSTEDO XR extended-release tablets are now available in the US. Read More>> Zydus Lifesciences receives USFDA approval for the hypertension drug Tadalafil It is used to treat pulmonary arterial hypertension and enhance exercise capacity. Tadalafil increases blood flow to specific body areas by relaxing blood vessel muscles. Read More>>Executive Movements Perrigo appoints Patrick Lockwood-Taylor as President, CEO, and Board member Lockwood-Taylor, previously with Bayer AG and The Oneida Group, brings experience in consumer health and achieved growth in his roles. He also chaired the Consumer Health Products Industry Association during his time at Procter and Gamble. Read More>> Virbac appoints Manuela Rodriguez as CSR (Corporate social responsibility) director She will report to Marc Bistuer, Director of Quality and Compliance, and bring 26 years of pharmaceutical industry experience. Read More>> Inizio expands leadership with new hires Inizio Medical appointed Matt Lewis as the Global Chief Artificial and Augmented Intelligence Officer and Paul Hatton as President of Medical Analytics and Innovation. With his experience as a Managing Director at Synaptik and Medical Expressions of Nucleus Global, Matt brings valuable leadership and innovation expertise to the team. Read More>>Financial and Market Activity Mankind Pharma Q4: Profits Rise By 52% YoY to Rs 294 Cr Mankind Pharma’s Q4FY23 Profit after tax surged by 52% YoY to USD 35.6 Mn, while FY23 profit dipped by 10% to USD 159 Mn. Revenue for FY23 increased by 12% to USD 1 Bn, and Q4FY23 revenue stood at USD 249 Mn. EBITDA for Q4FY23 rose by 45% to USD 50.8 Mn, but for FY23, it decreased by 5% to USD 232 Mn. Read More>>
Did you find the newsletter helpful? *|SURVEY: Yes|* *|SURVEY: No|*
Latest Industry Insights from Draup Braindesk
Athenahealth focuses on telehealth services that involve advanced technology and electronic communication for remote clinical & non-clinical care services and enhance more innovative access solutions for patients struggling with transportation, time, or access barriers where patients meet the doctors easily.
Neurology Treatment Solutions
Athenahealth aims to develop neurology treatment that helps to treat neurological diseases such as brain injury or diseases, head injury, spinal injury, brain tumors, spinal tumors, brain hemorrhage, and hydrocephalus for the patients
The company focuses on general neurology treatment to treat a wide range of neurology disorders with a full range of specialist areas like Stroke, Movement Disorders, Deep Brain Stimulation, Epilepsy, and Seizure Disorders
Electronic Health Record System
Athenahealth is keen on developing its mobile applications and cloud-based electronic health records (EHR) system with a virtual assistant and voice-driven capabilities that help clinicians to improve documentation accuracy, save time, and improve the patient experience
Service providers with rich expertise in Electronic Health Record System would be the deal winners
Company – Patheous Health Total Funding– USD 12.5 Mn About: Patheous Health offers Dysphagia Rx, a platform of diagnostic and therapeutic services. The platform improves outcomes, lower cost, and ensure that providers and patients have access to care. The company closed its venture equity funding round in early 2020 and acquired MBS Envision. Michael Peck and Correy Trupp formed the company in Leawood, Kansas, in 2019. Read More>>
Latest Reports Published in Draup
Zoetis, Inc. Account Intelligence Report
Zoetis is keen on developing the carcass data to the digital ecosystems for Performance Livestock Analytics and BLOCKYARD that enable more seamless management and genetics decision-making tools. Read More>>
UnitedHealth Group Incorporated – Account Intelligence Report
The company prioritizes AI-based Virtual Assistants and virtual wellness programs to enhance patient experiences and streamline administrative processes. Read More>>
Here’s what’s new on our Sales Intelligence Platform Introducing Outsourced Workloads and Tech Stack Developer filters in Universe
Effortlessly filter companies based on their outsourcing engagements using the new Outsourced Workloads filter in Universe.
Filter Accounts in Universe based on the Tech stack they use that is developed by specific developer companies.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
This website uses the following additional cookies:
Please enable Strictly Necessary Cookies first so that we can save your preferences!